Shares of Strides Pharma Science Ltd fell as much as 5.34 per cent to 472.40, their lowest since August 24 on USFDA observations.
The company said that the USFDA has issued Form 483 with three observations after inspecting its Bengaluru facility. The company believes that the observations are not material in nature.
The stock posted biggest intraday fall since July 16. As of last close, the stock had fallen 37.5 per cent this year.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.